Advances in targeting cyclic nucleotide phosphodiesterases
DH Maurice, H Ke, F Ahmad, Y Wang… - Nature reviews Drug …, 2014 - nature.com
Cyclic nucleotide phosphodiesterases (PDEs) catalyse the hydrolysis of cyclic AMP and
cyclic GMP, thereby regulating the intracellular concentrations of these cyclic nucleotides …
cyclic GMP, thereby regulating the intracellular concentrations of these cyclic nucleotides …
Vector platforms for gene therapy of inherited retinopathies
I Trapani, A Puppo, A Auricchio - Progress in retinal and eye research, 2014 - Elsevier
Inherited retinopathies (IR) are common untreatable blinding conditions. Most of them are
inherited as monogenic disorders, due to mutations in genes expressed in retinal …
inherited as monogenic disorders, due to mutations in genes expressed in retinal …
Lighting a candle in the dark: advances in genetics and gene therapy of recessive retinal dystrophies
Nonsyndromic recessive retinal dystrophies cause severe visual impairment due to the
death of photoreceptor and retinal pigment epithelium cells. These diseases until recently …
death of photoreceptor and retinal pigment epithelium cells. These diseases until recently …
Cyclic nucleotide phosphodiesterases: important signaling modulators and therapeutic targets
F Ahmad, T Murata, K Shimizu, E Degerman… - Oral …, 2015 - Wiley Online Library
By catalyzing hydrolysis of cyclic adenosine monophosphate (cAMP) and cyclic guanosine
monophosphate (cGMP), cyclic nucleotide phosphodiesterases are critical regulators of their …
monophosphate (cGMP), cyclic nucleotide phosphodiesterases are critical regulators of their …
Long-term safety and efficacy of human-induced pluripotent stem cell (iPS) grafts in a preclinical model of retinitis pigmentosa
Abstract The US Food and Drug Administration recently approved phase I/II clinical trials for
embryonic stem (ES) cell-based retinal pigmented epithelium (RPE) transplantation, but this …
embryonic stem (ES) cell-based retinal pigmented epithelium (RPE) transplantation, but this …
CRISPR repair reveals causative mutation in a preclinical model of retinitis pigmentosa
Massive parallel sequencing enables identification of numerous genetic variants in mutant
organisms, but determining pathogenicity of any one mutation can be daunting. The most …
organisms, but determining pathogenicity of any one mutation can be daunting. The most …
Advances in gene therapy for diseases of the eye
Over the last few years, huge progress has been made with regard to the understanding of
molecular mechanisms underlying the pathogenesis of neurodegenerative diseases of the …
molecular mechanisms underlying the pathogenesis of neurodegenerative diseases of the …
Gene therapy in inherited retinal degenerative diseases, a review
VKL Takahashi, JT Takiuti, R Jauregui… - Ophthalmic …, 2018 - Taylor & Francis
Hereditary diseases of the retina represent a group of diseases with several heterogeneous
mutations that have the common end result of progressive photoreceptor death leading to …
mutations that have the common end result of progressive photoreceptor death leading to …
Reprogramming metabolism by targeting sirtuin 6 attenuates retinal degeneration
L Zhang, J Du, S Justus, CW Hsu… - The Journal of …, 2016 - Am Soc Clin Investig
Retinitis pigmentosa (RP) encompasses a diverse group of Mendelian disorders leading to
progressive degeneration of rods and then cones. For reasons that remain unclear …
progressive degeneration of rods and then cones. For reasons that remain unclear …
The PDE6 mutation in the rd10 retinal degeneration mouse model causes protein mislocalization and instability and promotes cell death through increased ion influx
T Wang, J Reingruber, ML Woodruff… - Journal of Biological …, 2018 - ASBMB
The retinal degeneration model rd10 contains a missense mutation of the catalytic PDE6 β
subunit, which hydrolyzes cGMP in response to light. This model produces cell death more …
subunit, which hydrolyzes cGMP in response to light. This model produces cell death more …